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Abstract
Background: Though accumulated evidence proved the advantages of laparoscopic hepatectomy, bleeding still
remains the most important challenge in clinical practice. Our study aimed to compare the outcomes of Pringle
maneuver (PM) and selective hemihepatic vascular occlusion (SHVO) surgeries for patients with liver cavernous
hemangioma (LCH).
Methods: The SHVO (n = 26; mean age, 42) and PM (n = 78; mean age, 43) surgeries were performed in 104 LCH
patients from January 2006 to January 2015. The intraoperative (bleeding, arterial pressure, oxyhemoglobin
saturation, etc.) and postoperative parameters (anal exhaust time, complications, blood cell numbers, etc.) were
measured and compared between the two groups. Liver function of all these patients was detected by blood test
at 1-day preoperation, and at 1, 3, and 5 days postoperation.
Results: Both of the two surgeries were successfully performed without any mortality. The intraoperative systolic
arterial pressure and pulse in PM group were much higher than that in SHVO group (P < 0.01). The postoperative
liver function parameters such as alanine transaminase (ALT), aspartate transaminase (AST), and total bilirubin (TBIL)
increased much more in the PM group than that in the SHVO group compared with preoperation results (P < 0.05).
However, there were no statistical differences in intraoperative bleeding, blood transfusion, hepatic inflow occlusion
time, oxygen saturation occlusion, anal exhaust time and incidence of complications between the two groups (P > 0.05).
Conclusions: SHVO is safer with less ischemia reperfusion injury than PM surgery for hemangioma resection on patients
with LCH.
Keywords: Liver cavernous hemangioma (LCH), Pringle maneuver (PM), Selective hemihepatic vascular occlusion (SHVO),
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Background
Liver cavernous hemangioma (LCH) is one of the most
common benign tumors in liver, with incidence ranging
from 5 to 20 % [1]. Most of the LCHs are small in size,
and thus symptomatic in some patients require no treat-
ment. However, some patients still need operative inter-
ventions because of its life-threatening complications [2].
Recently, several methods have been reported for LCH
treatment, such as surgical resection [3], radiofrequency
ablation [4], microwave coagulation [5], radiotherapy [6],
etc. Among them, the surgical resection is reported to
be the most effective treatment with good postoperative
outcomes [3]. During surgical resection, bleeding is the
most important challenge. Blood transfusions have been
demonstrated to have a severe impact on long-term and
short-term outcomes, that is called ischemia reperfusion
injury [7]. Therefore, it is important to choose a suitable
surgical resection approach with minimized blood loss
for LCH treatment.
Pringle maneuver (PM) and selective hemihepatic vas-
cular occlusion (SHVO) methods are two common
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methods for liver resection. PM is a technique of transi-
ent inflow occlusion that was first described by Pringle
[8]. It is carried out by taping the hepatoduodenal liga-
ment and then using a vascular clamp or a tourniquet
until the hepatic arterial pulse disappears. Though the
validity of PM is reported to reduce hemorrhage in liver
resection, it usually induces ischemia reperfusion injury
in many cases [9, 10]. In order to avoid the ischemia re-
perfusion injury, the SHVO technique which can allow
normal blood supply at contralateral hemi-liver is pro-
posed [11]. However, this technique will induce more
bleeding from the other hemi-liver and will cause serious
complications.
Though many studies have compared the outcome of
these two techniques [12, 13], no consistent conclusion
has achieved until now, especially for patients with LCH
who need excision. A meta-analysis performed by Wang
et al. [14] evaluated the outcomes of PM and SHVO,
and the results suggested that SHVO did not offer more
satisfying benefit than PM in patients who suffered from
hepatic resection. However, a recent retrospective study
compared the clinical outcomes of PM and SHVO in pa-
tients with liver tumor who need liver resection, and
concluded that the SHVO using extra-Glissonian ap-
proach offers benefits of less blood loss and operative
time, as well as better recovery in liver resection [15].
In this study, we retrospectively evaluated the outcome
of the two techniques, PM and SHVO, aimed to find a
better one for hemangioma excision for LCH patients.
Methods
Patients
From January 2006 to January 2015, 104 patients with LCH
aged from 22 to 62 years (mean age: 42 years) who under-
went hepatic resection in the Department of Hepatobiliary
Surgery at the Ningxia Medical University were included in
this study. All these patients were operated because the
Child-Pugh score was class A, or the class B were adjusted
to class A. They were performed SHVO or PM.
All the patients signed an informed consent and this
study was approved by the local ethics research committee.
Surgical procedure
SHVO:
There are two different approaches to achieve vascular
occlusion in SHVO method, by liver parenchyma and by
hilar plate.
The approach by liver parenchyma was described as
follows: Firstly, a sharp knife was used to prick hole on
liver capsule, then a right-angle forceps was inserted into
the hole, and a blunt dissection was performed outside
the Glisson’s sheath. In order to protect the portal vein
and its small branches from damage, the forceps should
mobilize the liver parenchyma towards the caudate with
no resistance. At last, the sharp end of the forceps was
passed through the junction of portal vein furcation and
caudate lobe, and an 8-Fr catheter was introduced. The
blood flow in the right and left half of the liver can be
blocked when the catheter was crimpled during hepatic
resection.
The approach by hilar plate was described as follows:
A small incision was made in the base of the Glisson’s
sheath. Then the right-angle forceps was gently passed
through the plane between the hilar plate and the liver
to dissect the hilar plate outside the Gilsson’s sheath,
and the 8-Fr catheter was introduced. Finally, the vascu-
lar occlusion was achieved by tighten the catheter during
hepatic resection.
PM:
The PM was performed by encircling the hepatoduo-
denal ligament with the 8-Fr catheter, and applying with
15-min clamping and 5-min release period.
Intraoperative and postoperative evaluation
The intraoperative blood loss, blood transfusion, and oc-
clusion time were measured. Besides, the peripheral blood
pressure, pulse, and oxygen saturation occlusion were
monitored. We also detected the postoperative anal ex-
haust time, the volume of abdominal drainage, diaphrag-
matic fluid infection, pleural effusion infection, biliary
fistula, temperature, and peripheral blood. Liver function
of all these patients was detected by blood test at 1 day
preoperation, and at 1, 3, and 5 days postoperation.
Statistical analysis
Data were expressed as mean ± standard deviation (SD).
Comparison between groups was analyzed by t test. Re-
peated measures analysis of ANOVA was used to evalu-
ate the quantitative variables, while enumeration data
was determined by χ2 test. Significant difference was de-
fined as P < 0.05.
Results
Demographic data of patients
Of the 104 patients, 26 (males/females, 4/22) with mean
ages of 42.92 ± 11.47 years underwent SHVO surgery, and
78 (males/females, 24/54) with mean ages of 44.91 ±
8.52 years underwent PM surgery. In the two surgery
groups, 2 (7.69 %) and 9 (11.54 %) patients were diagnosed
as hepatitis, respectively. Of them, 2 (7.69 %) and 5
(64.10 %) patients were classified into Child-Pugh’s grade
B, respectively; these patients had been adjusted to Child-
Pugh’s grade A before surgery. The length of hospital stay
was 16.81 ± 4.70 days and 16.56 ± 5.50 days in the SHVO
group and the PM group, respectively. There were no sig-
nificant differences between the two groups in gender,
ages, hospital stay duration, and Child-Pugh’s classification
(P > 0.05) (Table 1). There were 8 patients in the SHVO
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group and 21 patients in the PM group underwent add-
itional cholecystectomy surgery.
Intraoperative outcome
The intraoperative outcome of the two groups was listed
in Table 2. Though the volume of blood loss and blood
transfusion was more in the SHVO group than that in the
PM group, the difference was insignificant (P > 0.05). Be-
sides, the difference of oxyhemoglobin saturation in the
two groups was also insignificant (P > 0.05). However, sig-
nificant difference was found between the two groups in
systolic arterial pressure and pulse (P < 0.01), indicating
that the effect of hemodynamics caused by SHVO surgery
was much less than that caused by PM surgery.
Postoperative outcome
No patients died during the perioperative period in the
two surgery groups. In the PM group, 1 patient was
found with diaphragmatic fluid infection, 2 were found
with pleural effusion infection, 1 was detected with bil-
iary fistula, 2 had raised body temperature, and 2 had
raised blood cell numbers. The patients’ numbers of
these complications in the SHVO group were 0, 2, 0, 1,
25, and 0, respectively. No statistical significance was
found in these complications between SHVO and PM
surgeries (P > 0.05). In addition, we also detected the
anal exhaust time and the volume of abdominal drain-
age, and found no significant difference between the two
groups as well (P > 0.05) (Table 3).
The liver function parameters such as alanine trans-
aminase (ALT), aspartate transaminase (AST), albumin
(ALB), and total bilirubin (TBIL) are presented in Table 4.
The results showed that all these liver function parameters
were significantly different between the SHVO and PM
groups after surgery. ALT, AST, and TBIL increased much
more in the PM group than that in the SHVO group com-
pared with preoperation results (P < 0.05). These results
suggested that PM surgery can significantly induce ische-
mia reperfusion injury of the liver.
Discussion
This study evaluated the intraoperative and postoperative
outcome of SHVO and PM surgeries for hemangioma ex-
cision in LCH patients. The results showed that the intra-
operative systolic arterial pressure and pulse in the PM
group were much higher than that in the SHVO group,
indicating that the effect of hemodynamics caused by
SHVO surgery was much less than that caused by PM
Table 1 Comparison of general conditions of the patients between the two groups
Surgery groups No. Gender (male/female) Age (year) Hospital stay (day) Hepatitis (yes/no) Child-Pugh’s grade (A/B)
SHVO 26 4/22 42.92 ± 11.47 16.81 ± 4.70 2/24 24/2
PM 78 24/54 44.91 ± 8.52 16.56 ± 5.50 9/96 73/5
t (χ2) 2.346 0.941 0.208 0.305 0.051
P >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
SHVO selective hemihepatic vascular occlusion, PM Pringle maneuver
Table 2 The comparison of intraoperative outcome between the two groups
SHVO PM t/F P
Blood loss (mL) 1116.92 ± 925.33 855.13 ± 669.15 t = 1.562 >0.05
Blood transfusion (mL) 1015.38 ± 840.81 896.15 ± 915.16 t = 0.587 >0.05
Occlusion time (min) 29.12 ± 10.62 24.46 ± 10.30 t = 1.986 =0.05
Systolic arterial pressure (mmHg) F = 7.878 <0.01
1-min before occlusion 121.65 ± 11.30 119.29 ± 11.56
1-min after occlusion 122.15 ± 12.23 145.13 ± 17.20
1-min after opening 119.04 ± 12.78 116.26 ± 13.37
Pulse (time) F = 9.208 <0.01
1-min before occlusion 79.19 ± 10.35 81.32 ± 10.64
1-min after occlusion 81.77 ± 8.68 96.14 ± 14.36
1-min after opening 79.04 ± 13.23 82.28 ± 12.59
Oxyhemoglobin saturation (%) F = 0.602 >0.05
1-min before occlusion 100.00 ± 0.00 99.99 ± 0.11
1-min after occlusion 100.00 ± 0.00 100.00 ± 0.00
1-min after opening 100.00 ± 0.00 99.98 ± 0.23
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surgery. In addition, the postoperative liver function pa-
rameters such as ALT, AST, and TBIL increased much
more in the PM group than that in the SHVO group
compared with preoperation results, suggesting that
PM surgery can significantly induce ischemia reperfu-
sion injury of the liver.
Liver is an organ that is sensitive to ischemia and an-
oxia. A loss of blood supply will result in reducing oxy-
gen supply to the liver and finally cause ischemia injury.
When the blood is transfused into the ischemic liver, it
will affect the activity of oxygen-dependent cells and
cause impairment of organ function. That is called ische-
mia reperfusion injury [9].
PM is a common surgical practice and gained wild ac-
ceptance due to its simple and time-saving advantages.
During PM surgery, intermittent clamping of hepatic in-
flow other than continuous clamping is proved safer [16].
Usually, 120 min is considered to be the safe upper limit
[17]. However, this technique is reported to cause severe
ischemia reperfusion injury even though it performed with
ischemic preconditioning [18]. The vascular occlusion, es-
pecially long time continuous occlusion, will result in un-
stable hemodynamics, increased arterial pressure, and
decreased cardiac index [16]. In this study, though we per-
formed the PM surgery with 15-min clamping and 5-min
release period, we also found that the patients in the PM
group showed much more increased intraoperative sys-
tolic arterial pressure and pulse than those in the SHVO
group. A recent study compared the short-term outcome
of patients who underwent hepatectomy with intermittent
clamping (ranging from 60 to 120 min) with those having
a clamping time more than 120 min, and suggested that
both of the two clamping frequencies are safe for patients
[19]. We believe that the clamping frequency is associated
with the blood loss and ischemia reperfusion injury during
surgery, thus, further research should be performed to
clarify these associations.
SHVO is a technique that can reduce the ischemia re-
perfusion injury by blocking blood supply of tumor loca-
tion at a hemihepatic portion and allowing normal blood
supply at the contralateral hemi-liver. SHVO surgery
over 60 min is possible and sufficient for hepatectomy
[20]. In the present study, the recovery of liver function
parameters in the SHVO group was as fast as that in the
PM group after surgery. Besides, the recovery in the
SHVO group had much less effect of ischemia reperfu-
sion injury than PM surgery. Our result was consistent
with a previous study reported by Ni et al., who com-
pared the outcomes between SHVO and PM surgeries
[21]. The results of this study showed that the PM sur-
gery was associated with much higher postoperative
ALT and AST levels than SHVO surgery. However, the
study did not compare the intraoperative outcomes be-
tween the two methods. Our results of the intraoperative
outcomes showed a significant difference between the
two groups in systolic arterial pressure and pulse, indi-
cating that the effect of hemodynamics caused by SHVO
surgery was much less than that caused by PM surgery.
Therefore, more evidence from our results demonstrated
that SHVO is an efficient method in recovery of liver
function without any short-term complications after sur-
gery for LCH patients who need hemangioma excision.
However, this technique is a complicated and difficult
surgery. Surgeons should have experience in dissecting
the porta hepatis and lowering hilar plate to protect the
vessels and bile ducts from injury [10]. Besides, before
surgery, surgeons should be aware of the position and
size of the lesions, as well as the preoperative liver func-
tion index.
There are several limitations that exist in our study.
Firstly, the patient size is small and most patients are
women. As we know, LCH is a liver disease that are
most frequently seen in women, and most of the patients
need no surgery [22, 23]. That is the reason why only
104 patients were included in this study during 9 years.
Besides, a surgeon’s experience and preference remain
the possible factors in deciding the most appropriate
methods to be used in clinical practice. Therefore, more
patients and multicenter trials are needed to acquire
more reliable data in future studies. Secondly, we just
compared the short-term postoperative outcome of the
SHVO and PM surgeries, thus long-term follow-up
should be performed to completely analyze the feasibility
of the two methods.
Table 3 The comparison of postoperative outcome between the two groups
SHVO PM t/χ2 P
Anal exhaust time (d) 3.15 ± 0.54 3.14 ± 0.42 t = 0.125 >0.05
Volume of abdominal drainage (mL) 312.00 ± 375.51 354.85 ± 358.33 t = 0.643 >0.05
Diaphragmatic fluid infection (yes/no) 0/26 1/77 χ2 = 0.337 >0.05
Pleural effusion infection (yes/no) 2/24 2/76 χ2 = 1.387 >0.05
Biliary fistula (yes/no) 0/26 1/77 χ2 = 0.337 >0.05
Body temperature (increased/not increased) 1/25 2/76 χ2 = 0.114 >0.05
Blood cell numbers (increased/back to normal) 0/26 2/76 χ2 = 0.680 >0.05
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Table 4 The liver function parameters of the patients in the two groups before and after surgery
Liver
function
SHVO PM F P
1-day before surgery 1-day after surgery 3-day after surgery 5-day after surgery 1-day before surgery 1-day after surgery 3-day after surgery 5-day after surgery
ALT (IU/L) 21.58 ± 19.66 462.77 ± 293.19 321.52 ± 209.53 138.83 ± 91.72 20.77 ± 30.92 650.46 ± 421.77 449.00 ± 412.24 236.59 ± 199.01 4.078 <0.05
AST (IU/L) 19.42 ± 4.93 506.18 ± 370.87 237.26 ± 199.95 66.08 ± 53.11 22.20 ± 23.24 683.62 ± 427.03 368.05 ± 346.49 124.40 ± 160.56 4.250 <0.05
ALB (g/L) 39.54 ± 3.47 31.88 ± 5.66 34.33 ± 3.71 40.45 ± 3.50 39.61 ± 5.11 27.31 ± 5.32 30.06 ± 4.00 35.25 ± 4.60 27.071 <0.01
TBIL (μmol/L) 11.70 ± 5.37 15.50 ± 7.07 16.90 ± 7.35 16.91 ± 3.83 12.02 ± 5.00 18.15 ± 6.98 19.78 ± 6.88 19.67 ± 6.60 4.733 <0.05













In summary, our study compared the short-term out-
comes of SHVO and PM surgeries on LHC patients and
demonstrated that SHVO is safer with less ischemia re-
perfusion injury than PM surgery. However, further
studies with more patients and long-term follow-up du-
rations are required to compare the safety and effective-
ness of the two techniques.
1. The efficacy and safety of PM and SHVO surgeries
were evaluated.
2. Arterial pressure and pulse in PM group were much
higher than that in SHVO group.
3. Liver function parameters increased much more in
PM group than that in SHVO group.
4. SHVO is safer with less ischemia reperfusion injury
than PM surgery.
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